NB73, a small-compound inhibitor of FOXM1, inhibits MM cell growth by promoting FOXM1 degradation, suggesting that NB73 could become a promising OXPHOS-targeted drug [53]. The gene discussed is FOXM1; the disease is Miyoshi myopathy.